glp 1 agonist and heart failure The cardiovascular effects of GLP-1 receptor agonists beyond obesity type 2 diabetes: An anti-atherosclerotic action Impact of GLP-1 receptor agonists

Resmetirom, the first FDA-approved drug for MASH: from drug discovery and action mechanisms to clinical trials

CME INDIA Presentation by Dr

doi: 10.1097/mca.0000000000000830, PMID: [DOI] [PubMed] [Google Scholar] 13

I recommend speaking with our team first so we can discuss whether this fits your current health picture and how it can be integrated with any other support you may be receiving

The standard of care involves a multidisciplinary team consisting of a diabetologist, a gastroenterologist with motility expertise, a certified diabetes educator, a registered dietician and a behavioral psychologist and/or a psychiatrist

Mendivil CO, Koziel H, Brain JD